SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced results for its fiscal 2014 third quarter.
Commenting on the Company’s performance, SurModics’ President and Chief Executive Officer Gary Maharaj said, “Despite headwinds faced by our Medical Device customers, we were able to generate revenue from non-coronary markets and post solid growth in that segment in our third quarter.
Help employers find you! Check out all the jobs and post your resume.
